ICD-10-CM Code C67

Malignant neoplasm of bladder

Version 2021 Non-Billable Code

Not Valid for Submission

C67 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of bladder. The code is NOT valid for the year 2021 for the submission of HIPAA-covered transactions.

ICD-10:C67
Short Description:Malignant neoplasm of bladder
Long Description:Malignant neoplasm of bladder

Consider the following ICD-10 codes with a higher level of specificity:

  • C67.0 - Malignant neoplasm of trigone of bladder
  • C67.1 - Malignant neoplasm of dome of bladder
  • C67.2 - Malignant neoplasm of lateral wall of bladder
  • C67.3 - Malignant neoplasm of anterior wall of bladder
  • C67.4 - Malignant neoplasm of posterior wall of bladder
  • C67.5 - Malignant neoplasm of bladder neck
  • C67.6 - Malignant neoplasm of ureteric orifice
  • C67.7 - Malignant neoplasm of urachus
  • C67.8 - Malignant neoplasm of overlapping sites of bladder
  • C67.9 - ... unspecified

Code Classification

  • Neoplasms (C00–D48)
    • Malignant neoplasms of urinary tract (C64-C68)
      • Malignant neoplasm of bladder (C67)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Information for Patients


Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include

  • Blood in your urine
  • A frequent urge to urinate
  • Pain when you urinate
  • Low back pain

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute

  • Bladder biopsy (Medical Encyclopedia)
  • Bladder cancer (Medical Encyclopedia)
  • Cancer - renal pelvis or ureter (Medical Encyclopedia)

[Learn More]

Bladder cancer Bladder cancer is a disease in which certain cells in the bladder become abnormal and multiply uncontrollably to form a tumor. The bladder is a muscular organ in the lower abdomen that stores urine until it can be removed (excreted) from the body.Bladder cancer may cause blood in the urine, pain during urination, frequent urination, the feeling of needing to urinate without being able to, or lower back pain. Many of these signs and symptoms are nonspecific, which means they may occur in multiple disorders. People who have one or more of these nonspecific health problems often do not have bladder cancer, but another condition such as an infection.The most common type of bladder cancer, called non-muscle invasive bladder cancer (NMIBC), involves cells lining the inside of the bladder. NMIBC generally does not spread to other tissues (metastasize), but it often does recur after it has been treated. The other type, called muscle-invasive bladder cancer (MIBC), involves cells of the muscle wall of the bladder. MIBC generally does metastasize and is often life-threatening.
[Learn More]